NCT07419841
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07419841
Title A Phase 1 Study of the Safety and Tolerability of CTX-10726
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Compass Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.